NEW YORK / RankWire.AI / – On Wednesday, U.S. equity markets saw modest increases as yields on long-term Treasury bonds dropped sharply. The S&P 500 gained 16.22 points, or 0.21%, closing at 7,707.98 and ending a streak of three consecutive losses. Meanwhile, the Dow Jones Industrial Average rose by 119.65 points, or 0.22%, finishing at 53,463.05. The Nasdaq Composite increased by 41.38 points, or 0.16%, to end at 26,331.09. Declines in government bond yields helped major indexes recover after recent sessions were pressured by rising borrowing costs.
In the early hours, bond prices experienced an uptick following the U.S. Treasury Department’s announcement of expanded liquidity support through larger buybacks of longer-dated government debt. Beginning September 9, the maximum size of each purchase will be increased from $2 billion to at least $4 billion per operation. This adjustment applies to nominal coupon securities with maturities in the 10-to-20-year and 20-to-30-year ranges. The new volume levels will remain in effect through November 4. The department attributed the decision to strong demand for high-quality offers in those sectors, which supported increased liquidity operations.
Following the announcement, Treasury yields decreased, reversing part of the recent upward trend in long-term borrowing costs. The 10-year Treasury yield dropped to approximately 4.65%, while the 30-year yield declined to about 5.20%. Notably, the 30-year yield had reached 5.337% on Tuesday, its highest since 2007. Since bond prices move inversely to yields, the higher demand for government debt caused yields to fall. This decline eased the pressure that had built up during the recent selloff of longer-term bonds.
Healthcare Sector Boosts Market Sentiment
During Wednesday’s trading, healthcare stocks emerged as a key contributor to the positive momentum, with several pharmaceutical companies posting significant gains. Moderna’s shares soared by 177%, while Merck advanced 12.6% following the release of promising results from a Phase 3 melanoma trial. The INTerpath-001 study evaluated the combination of personalized mRNA therapy intismeran autogene with Keytruda after surgical removal of high-risk melanoma. The trial successfully met its primary endpoint for recurrence-free survival and also achieved a key secondary endpoint measuring survival without distant cancer spread.
This rally in healthcare stocks helped offset mixed performances in other sectors, especially within technology. Consumer-focused shares also contributed to the day’s gains, buoyed by several companies reporting quarterly earnings. Estée Lauder surged over 16% after its earnings release, adding to the positive trend among consumer stocks. Target and Lowe’s also moved higher following their latest financial disclosures. Smaller firms generally outperformed their larger counterparts, with the Russell 2000 index increasing approximately 0.5% as the broader market regained ground.
Major Indexes End Three-Day Losing Streak
The rally on Wednesday marked the end of a three-session decline for the S&P 500, Dow, and Nasdaq. The recovery followed a period where rising long-term yields had negatively impacted equities earlier in the week. Despite Wednesday’s gains, the main indexes remained down for the week as trading closed. The S&P 500 was roughly 1% below last Friday’s level, while the Dow had declined about 0.5%, and the Nasdaq was down approximately 1.5% for the week.
Looking at the broader yearly performance, the indexes still showed positive results despite this week’s dip and the recent bond market pressure. As of Wednesday’s close, the S&P 500 had gained around 12.6% since the start of the year. The Dow was up approximately 11.2%, and the Nasdaq outperformed with an increase of about 13.3%, reflecting its stronger year-to-date gains. Wednesday’s session, therefore, represented a modest recovery for Wall Street, driven by falling Treasury yields and healthcare sector advancements that lifted all three major U.S. stock indexes.